SCD and type 2 diabetes mellitus: Thus, the possible impaired conversion of stearic acid to oleic acid might be a contributing factor to why some diabetes patients do not obtain remission after RYGB suggesting delta‐9‐desaturase to be a possible target in treating Type 2 diabetes [29].